Cargando…

Association of cardiovascular events and lipoprotein particle size: Development of a risk score based on functional data analysis

BACKGROUND: Functional data is data represented by functions (curves or surfaces of a low-dimensional index). Functional data often arise when measurements are collected over time or across locations. In the field of medicine, plasma lipoprotein particles can be quantified according to particle diam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rowland, Charles M., Shiffman, Dov, Caulfield, Michael, Garcia, Veronica, Melander, Olle, Hastie, Trevor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405139/ https://www.ncbi.nlm.nih.gov/pubmed/30845215 http://dx.doi.org/10.1371/journal.pone.0213172

Ejemplares similares

Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost-effectiveness analysis
por: Shiffman, Dov, et al.
Publicado: (2016)

Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history
por: Tada, Hayato, et al.
Publicado: (2016)

Metabolic Mediators of the Effects of Family History and Genetic Risk Score on Coronary Heart Disease—Findings From the Malmö Diet and Cancer Study
por: Fritz, Josef, et al.
Publicado: (2017)

The relationship between insulin resistance and ion mobility lipoprotein fractions
por: Rowland, Charles M., et al.
Publicado: (2022)

An Insulin Resistance Score Improved Diabetes Risk Assessment in the Malmö Prevention Project—A Longitudinal Population-Based Study of Older Europeans
por: Shiffman, Dov, et al.
Publicado: (2021)

Concordance of Cardiovascular Risk Factors and Behaviors in a Multiethnic US Nationwide Cohort of Married Couples and Domestic Partners
por: Shiffman, Dov, et al.
Publicado: (2020)

Adiponectin and Lipoprotein Particle Size
por: Weiss, Ram, et al.
Publicado: (2009)

Hemoglobin level and lipoprotein particle size
por: Hämäläinen, Päivi, et al.
Publicado: (2018)

Lipoprotein Particle Predictors of Arterial Stiffness after 17 Years of Follow Up: The Malmö Diet and Cancer Study
por: Hartz, Jacob, et al.
Publicado: (2020)

Relation between high density lipoprotein particles concentration and cardiovascular events: a meta-analysis
por: Wu, YuJing, et al.
Publicado: (2018)

Impact of genetic risk score on the association between male childlessness and cardiovascular disease and mortality
por: Elenkov, Angel, et al.
Publicado: (2021)

Lipidomic risk scores are independent of polygenic risk scores and can predict incidence of diabetes and cardiovascular disease in a large population cohort
por: Lauber, Chris, et al.
Publicado: (2022)

OR02-2 The Relationship of Lipoprotein Fractions as Assessed by Ion Mobility and Insulin Resistance as Measured by the Insulin Suppression Test
por: Abbasi, Fahim, et al.
Publicado: (2022)

A genetic risk score for CAD, psychological stress, and their interaction as predictors of CAD, fatal MI, non-fatal MI and cardiovascular death
por: Svensson, Thomas, et al.
Publicado: (2017)

Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study
por: Sokooti, Sara, et al.
Publicado: (2021)

Insulin Resistance Probability Scores for Apparently Healthy Individuals
por: Abbasi, Fahim, et al.
Publicado: (2018)

Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome
por: Kim, Dal-Sik, et al.
Publicado: (2010)

Associations between smoking, components of metabolic syndrome and lipoprotein particle size
por: Slagter, Sandra N, et al.
Publicado: (2013)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

Genome-Wide Study of Gene Variants Associated with Differential Cardiovascular Event Reduction by Pravastatin Therapy
por: Shiffman, Dov, et al.
Publicado: (2012)

Biomarkers of blood cadmium and incidence of cardiovascular events in non-smokers: results from a population-based proteomics study
por: Borné, Yan, et al.
Publicado: (2019)

Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults
por: Haslam, Danielle E, et al.
Publicado: (2022)

Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death
por: Schomburg, Lutz, et al.
Publicado: (2019)

In Vivo Insulin Sensitivity and Lipoprotein Particle Size and Concentration in Black and White Children
por: Burns, Stephen F., et al.
Publicado: (2009)

The Effect of Insulin Resistance and Obesity on Low−Density Lipoprotein Particle Size in Children
por: Taşcılar, Mehmet Emre, et al.
Publicado: (2010)

Lipoprotein particles in patients with pediatric Cushing disease and possible cardiovascular risks
por: Makri, Angeliki, et al.
Publicado: (2019)

Polygenic Risk Score for Coronary Heart Disease Modifies the Elevated Risk by Cigarette Smoking for Disease Incidence
por: Hindy, George, et al.
Publicado: (2018)

The Relationship between Daily Fructose Consumption and Oxidized Low-Density Lipoprotein and Low-Density Lipoprotein Particle Size in Children with Obesity
por: Gungor, Ali, et al.
Publicado: (2021)

High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients
por: Tanaka, Sébastien, et al.
Publicado: (2019)

Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III
por: Pechlaner, Raimund, et al.
Publicado: (2017)

Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men
por: Teleka, Stanley, et al.
Publicado: (2022)

A genetic risk score for fasting plasma glucose is independently associated with arterial stiffness: a Mendelian randomization study
por: Gottsäter, Mikael, et al.
Publicado: (2018)

Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease
por: Smith, Einar, et al.
Publicado: (2020)

Hyperglycaemia-associated Caspase-3 predicts diabetes and coronary artery disease events
por: Sun, Jiangming, et al.
Publicado: (2021)

Cardiometabolic Polygenic Risk Scores and Osteoarthritis Outcomes: A Mendelian Randomization Study Using Data From the Malmö Diet and Cancer Study and the UK Biobank
por: Hindy, George, et al.
Publicado: (2019)

Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in Women
por: Mora, Samia, et al.
Publicado: (2010)

Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity
por: Razavi, Amirnader Emami, et al.
Publicado: (2012)

High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes
por: Tian, Li, et al.
Publicado: (2012)

Low-Density-Lipoprotein Particle Size Predicts a Poor Outcome in Patients with Atherothrombotic Stroke
por: Song, Tae-Jin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_47m6577p6tr6rjm11ompmkkr8t